ATA21096A - Neue formen von paroxetin-hydrochlorid-anhydrat - Google Patents

Neue formen von paroxetin-hydrochlorid-anhydrat

Info

Publication number
ATA21096A
ATA21096A AT0021096A AT21096A ATA21096A AT A21096 A ATA21096 A AT A21096A AT 0021096 A AT0021096 A AT 0021096A AT 21096 A AT21096 A AT 21096A AT A21096 A ATA21096 A AT A21096A
Authority
AT
Austria
Prior art keywords
new forms
paroxetine hydrochloride
hydrochloride anhydrate
anhydrate
paroxetine
Prior art date
Application number
AT0021096A
Other languages
English (en)
Other versions
AT407528B (de
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA21096(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en
Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en
Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ATA21096A publication Critical patent/ATA21096A/de
Application granted granted Critical
Publication of AT407528B publication Critical patent/AT407528B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0021096A 1995-02-06 1996-02-05 Neue formen von paroxetin-hydrochlorid-anhydrat AT407528B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound
GBGB9503112.6A GB9503112D0 (en) 1995-02-17 1995-02-17 Novel compound
GBGB9509807.5A GB9509807D0 (en) 1995-05-15 1995-05-15 Novel compounds

Publications (2)

Publication Number Publication Date
ATA21096A true ATA21096A (de) 2000-08-15
AT407528B AT407528B (de) 2001-04-25

Family

ID=27267578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0021096A AT407528B (de) 1995-02-06 1996-02-05 Neue formen von paroxetin-hydrochlorid-anhydrat

Country Status (47)

Country Link
EP (3) EP0808314B1 (de)
JP (2) JP2915338B2 (de)
KR (1) KR100289885B1 (de)
CN (3) CN1289496C (de)
AR (2) AR001982A1 (de)
AT (1) AT407528B (de)
AU (2) AU4786496A (de)
BE (1) BE1009112A3 (de)
BG (1) BG62967B1 (de)
BR (1) BR9600534A (de)
CA (3) CA2210023C (de)
CH (3) CH688353A5 (de)
CZ (1) CZ297171B6 (de)
DE (3) DE69631298T2 (de)
DK (2) DK11996A (de)
DZ (1) DZ1989A1 (de)
ES (1) ES2114471B1 (de)
FI (3) FI111544B (de)
FR (1) FR2730232B1 (de)
GR (1) GR1002466B (de)
HK (1) HK59397A (de)
HU (1) HUP9600255A1 (de)
IE (1) IE80500B1 (de)
IL (1) IL117035A (de)
IT (1) IT1289532B1 (de)
LU (1) LU88711A1 (de)
LV (1) LV11618B (de)
MA (1) MA23802A1 (de)
MC (1) MC2411A1 (de)
MX (1) MX9600484A (de)
MY (1) MY132529A (de)
NL (1) NL1002248C2 (de)
NO (3) NO301009B1 (de)
NZ (1) NZ280943A (de)
OA (1) OA10261A (de)
PL (1) PL189247B1 (de)
PT (1) PT101827B (de)
RO (1) RO112426B1 (de)
RU (1) RU2125052C1 (de)
SE (1) SE521084C2 (de)
SG (1) SG43787A1 (de)
SI (2) SI21923B (de)
SK (1) SK283608B6 (de)
TR (1) TR199600096A2 (de)
TW (1) TW503238B (de)
UA (1) UA49796C2 (de)
WO (1) WO1996024595A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1384720A1 (de) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Verfahren zur Trocknung von Paroxetinhydrochlorid
JP2000514653A (ja) * 1996-07-15 2000-11-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 立体特異的分割のためのエステラーゼのスクリーニングおよびその使用
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
KR100543614B1 (ko) * 1997-06-10 2006-01-20 신톤 비.브이. 4-페닐피페리딘 화합물
ATE207065T1 (de) * 1997-08-08 2001-11-15 Aventis Pharma Gmbh Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
BR9908825A (pt) * 1998-03-16 2000-11-21 Smithkline Beecham Plc Forma cristalina de paroxetina
AU2003200534B2 (en) * 1998-03-24 2004-12-02 Smithkline Beecham Plc Paroxetine compositions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
JP3796351B2 (ja) 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
CA2339857A1 (en) * 1998-08-07 2000-02-17 Neal Ward Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826176D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826175D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
EP1135383B1 (de) * 1998-11-30 2003-12-03 SmithKline Beecham plc Gemischte paroxetin-propan-2-olsolvate
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
IT1308629B1 (it) * 1999-02-23 2002-01-09 Recordati Chem Pharm Processo per la produzione di paroxetina.
WO2000054775A1 (de) * 1999-03-12 2000-09-21 Basf Ag Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB9914585D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
SE9902550D0 (sv) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923445D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
JPWO2002022609A1 (ja) * 2000-09-14 2004-01-22 旭硝子株式会社 実質的に有機溶媒を含まないパロキセチン塩類の製造方法
WO2003072104A1 (en) * 2002-02-22 2003-09-04 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
EP1828098A1 (de) * 2005-11-22 2007-09-05 Teva Pharmaceutical Industries Ltd Kristallformen von cinacalcet hci und verfahren zu ihrer herstellung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
ES2058061T3 (es) 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
WO1992009281A2 (en) * 1990-11-24 1992-06-11 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
TR199600096A2 (tr) 1996-08-21
CN1310180A (zh) 2001-08-29
CN1090187C (zh) 2002-09-04
DE69631298T2 (de) 2004-11-18
RO112426B1 (ro) 1997-09-30
IL117035A (en) 2000-02-29
MA23802A1 (fr) 1996-10-01
EP0808314B1 (de) 2002-06-12
WO1996024595A1 (en) 1996-08-15
CH689229A5 (de) 1998-12-31
GR1002466B (el) 1996-11-06
SK283608B6 (sk) 2003-10-07
IT1289532B1 (it) 1998-10-15
SE521084C2 (sv) 2003-09-30
UA49796C2 (uk) 2002-10-15
KR960031409A (ko) 1996-09-17
NO20015070D0 (no) 2001-10-18
CZ32096A3 (en) 1996-08-14
DE19603797A1 (de) 1996-08-14
AU4786496A (en) 1996-08-27
NO960472D0 (no) 1996-02-05
NO301009B1 (no) 1997-09-01
LV11618A (lv) 1996-12-20
CA2210022C (en) 2005-09-13
EP0808314A1 (de) 1997-11-26
OA10261A (en) 1997-09-19
NO970939L (no) 1996-08-07
CA2168829C (en) 1997-12-16
NO311519B1 (no) 2001-12-03
CZ297171B6 (cs) 2006-09-13
CA2211522A1 (en) 1996-08-07
EP1378508A1 (de) 2004-01-07
BG100333A (bg) 1996-08-30
FI960519A0 (fi) 1996-02-05
DE19603797C2 (de) 1998-11-12
SK14396A3 (en) 1996-11-06
DE69621777T2 (de) 2003-01-02
CN1216055C (zh) 2005-08-24
NO20015070L (no) 1996-08-07
PT101827A (pt) 1996-09-30
BR9600534A (pt) 1997-05-13
PL312646A1 (en) 1996-08-19
HU9600255D0 (en) 1996-03-28
LU88711A1 (fr) 1996-08-23
CN1636993A (zh) 2005-07-13
FI960519L (fi) 1996-08-07
LV11618B (en) 1997-04-20
DK11996A (da) 1996-08-07
CH689804A5 (de) 1999-11-30
DK200100223A (de) 2001-02-12
AR001982A1 (es) 1998-01-07
ES2114471A1 (es) 1998-05-16
FI111544B (fi) 2003-08-15
IE80500B1 (en) 1998-08-12
CA2211522C (en) 1999-12-07
FI20030370A7 (fi) 2003-03-12
AU701518C (en) 2006-12-07
FI20030162L (fi) 2003-02-03
MX9600484A (es) 1997-01-31
FR2730232A1 (fr) 1996-08-09
SG43787A1 (en) 1997-11-14
AU701518B2 (en) 1999-01-28
PT101827B (pt) 1997-08-29
DE69621777D1 (de) 2002-07-18
BG62967B1 (bg) 2000-12-29
SE9600406L (sv) 1996-08-07
ES2114471B1 (es) 1999-08-16
IL117035A0 (en) 1996-09-12
CN1143643A (zh) 1997-02-26
NL1002248C2 (nl) 1996-09-11
MY132529A (en) 2007-10-31
IE960104A1 (en) 1996-08-07
NO301009B3 (de) 2003-01-06
FI20030370L (fi) 2003-03-12
CA2210022A1 (en) 1996-08-07
NL1002248A1 (nl) 1996-08-06
DE69631298D1 (de) 2004-02-12
EP1136490A1 (de) 2001-09-26
JPH11228571A (ja) 1999-08-24
BE1009112A3 (fr) 1996-11-05
TW503238B (en) 2002-09-21
ITMI960203A0 (de) 1996-02-05
HUP9600255A1 (en) 1997-03-28
SI9600036B (sl) 2006-12-31
MC2411A1 (fr) 1996-12-02
NO970939D0 (no) 1997-02-28
JPH08245620A (ja) 1996-09-24
JP2915338B2 (ja) 1999-07-05
SI9600036A (en) 1996-10-31
KR100289885B1 (ko) 2001-05-15
CA2210023A1 (en) 1996-08-07
CA2210023C (en) 1999-02-09
AR036856A2 (es) 2004-10-06
CN1289496C (zh) 2006-12-13
EP1136490B1 (de) 2004-01-07
CH688353A5 (de) 1997-08-15
SI21923A (sl) 2006-06-30
ITMI960203A1 (it) 1997-08-05
AU4332896A (en) 1996-08-15
HK59397A (en) 1997-05-16
FI20030162A7 (fi) 2003-02-03
SE9600406D0 (sv) 1996-02-05
CA2168829A1 (en) 1996-08-07
SI21923B (sl) 2006-12-31
MX198371B (de) 2000-08-29
PL189247B1 (pl) 2005-07-29
FR2730232B1 (fr) 1997-08-01
NO960472L (no) 1996-08-07
AT407528B (de) 2001-04-25
RU2125052C1 (ru) 1999-01-20
DZ1989A1 (fr) 2002-10-15
NZ280943A (en) 1997-01-29

Similar Documents

Publication Publication Date Title
ATA21096A (de) Neue formen von paroxetin-hydrochlorid-anhydrat
DE19681286T1 (de) Neue Kristallform von Olanzapin
DE69631390D1 (de) Substituierte Benzylaminpiperidin-Verbindungen
DE69704469D1 (de) Hertellungsverfahren von Acrylnitril-modifizierten Tonerzusammensetzungen
DE69604996D1 (de) Halbbrückentreiberschaltung
EP0791009A4 (de) Modifizierter neuropeptid-y-rezeptor
ATE231521T1 (de) Kristalline formen von eto2c-ch2-(r)cgl-aze-pab- oh
TR199600382A2 (tr) Nöropeptid Y1'e özgü baglar.
FI960516L (fi) Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
DE59503068D1 (de) Übergangsbrücke
DE69607261D1 (de) Anschlussbrücke
DE69627732D1 (de) Modifizierte Zusammensetzung von Asphaltzement
DE69522582D1 (de) NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN
ATE293113T1 (de) Neue polymorphe formen von olanzapin
ATE205200T1 (de) Neue carboxy-substituierte cyclische carboxamidderivate
ATE202556T1 (de) Neue formen der organischen salze des n'n- diacetylcystins
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
DE59501871D1 (de) Monocarbonsäureamide von Polyaminen
DE59500958D1 (de) Gliederbrücke
KR960022819U (ko) 교량의 신축이음장치의 덮개판
KR960031694U (ko) 콘크리트로 만든 폼타이용 콘-넛트
KR970002377U (ko) 조명등용 안정기 고정장치
KR960013117U (ko) 대다리
KR960037880U (ko) 두부를 볼트로 형성한 못
BR1101056A (pt) Derivados de n-(4-piperidinil) (dihidrobenzofurano ou dihidro-2h-benzopirano) carboxamida

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
MM01 Lapse because of not paying annual fees

Effective date: 20130815